July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Genetic variants in microRNA genes and microRNA binding sites associated with diabetic retinopathy
Author Affiliations & Notes
  • Ebony Liu
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Georgia Kaidonis
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Bennet McComish
    Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
  • Mark C Gillies
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
  • Sotoodeh Abhary
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Mark Daniell
    Centre for Eye Research Australia, Melbourne, Victoria, Australia
  • Nikolai Petrovsky
    Department of Diabetes and Endocrinology, Flinders University, Adelaide, South Australia, Australia
  • Jonathan Gleadle
    Department of Medicine, Flinders University, Adelaide, South Australia, Australia
  • Jamie E. Craig
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Kathryn P Burdon
    Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
  • Footnotes
    Commercial Relationships   Ebony Liu, None; Georgia Kaidonis, None; Bennet McComish, None; Mark Gillies, None; Sotoodeh Abhary, None; Mark Daniell, None; Nikolai Petrovsky, None; Jonathan Gleadle, None; Jamie Craig, None; Kathryn Burdon, None
  • Footnotes
    Support  Australia: Center for Research Excellence (clinical research) grant for 2017.
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3017. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ebony Liu, Georgia Kaidonis, Bennet McComish, Mark C Gillies, Sotoodeh Abhary, Mark Daniell, Nikolai Petrovsky, Jonathan Gleadle, Jamie E. Craig, Kathryn P Burdon; Genetic variants in microRNA genes and microRNA binding sites associated with diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3017.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Genetic variants in microRNA genes and microRNA binding sites have not been studied systematically in association with diabetic retinopathy (DR). We conducted a comprehensive search for single nucleotide polymorphisms (SNPs) in microRNA genes and microRNA binding sites utilizing data from a previous genome wide association study (GWAS) of Australian patients.

Methods : SNPs in microRNA genes and microRNA binding sites were obtained from the miRNASNP and PolymiRTS (version 2) online databases, and then imputed in cases and controls from our previous GWAS data using the Illumina OmniExpress array (n=1598). Analysis for association with DR and vision threatening DR (proliferative DR or clinically significant macula edema) were performed for type 1 and type 2 diabetes separately. Top ranking SNPs were selected by looking at their adjusted p values, odd ratios and significance in similar phenotype groups. These SNP were genotyped in a larger cohort that included the previous GWAS cohort (n=3694) to confirm their association with DR.

Results : 208 SNPs in microRNA genes and 41578 SNPs in microRNA binding sites were able to be imputed from the GWAS data. Most significant p-values adjusted for age, sex and HbA1c were less than 0.01 and 0.0001 for 16 microRNA SNPs and 18 microRNA binding site SNPs respectively, in relation to either the presence of DR or vision threatening DR compared with diabetic controls (no DR). None reached significance after Bonferroni correction. 46 top ranking SNPs were selected for subsequent genotyping in a larger cohort. SNPs selected included genes encoding upstream and downstream components of the NF-κB, TNFα, MAPK and VEGF pathways (LHX6, NLRP3, PCDH7, ALCAM, ADAMTS5, mir23A), endothelial cell adhesion and proliferation (GLG1, AFAP1) and immune system function (CD209, HLA-DPB1, MYSM1, CHST15).

Conclusions : A number of microRNA and microRNA binding sites in several highly relevant genes have been identified to be potentially significant in the development and severity of DR. These findings will be confirmed by genotyping the variants in a larger and more powerful cohort.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×